$129.00
You’ll be briefly redirected to Link Money, our secure ACH payment partner, to connect your bank and complete payment.– Your bank login is never visible to or stored by us – Encrypted, bank-level security – A standard, trusted payment process
In laboratory environments, CJC-1295 No DAC is studied to investigate growth hormone releasing hormone signaling and its role in endocrine regulation. Researchers frequently examine how this peptide interacts with receptors in the pituitary gland to influence growth hormone release and downstream signaling pathways.
Experimental models often focus on transient or pulsatile endocrine signaling patterns, allowing researchers to analyze how short-acting GHRH analogs influence cellular communication within hormone-regulated systems. These studies commonly explore signaling pathways associated with growth hormone, metabolic regulation, and cellular response to endocrine stimulation.
Scientific literature also examines how GHRH analogs interact with broader hormonal signaling networks, including pathways influenced by growth hormone and related endocrine regulators. These investigations remain confined strictly to laboratory research contexts and do not represent approved therapeutic applications.
CJC 1295 No DAC is used for research use in studies exploring growth hormone signaling, GH secretion, GH levels, and GH pulse dynamics. Researchers examine its interaction with the GHRH receptor, endogenous GH, and IGF-1 levels in controlled lab environments. It is commonly compared with CJC 1295 DAC to understand the role of the Drug Affinity Complex in peptide stability and signaling duration.
Unlike CJC 1295 DAC, CJC 1295 No DAC does not include a Drug Affinity Complex, resulting in a shorter half life and more transient activity. This makes it useful in peptide therapy research models investigating natural GH pulses, frequent dosing, and receptor desensitization. These distinctions are valuable in peptide research and comparative lab tests.
This lyophilized peptide is reconstituted in laboratory settings using an appropriate reconstitution solution, commonly bacteriostatic water, for research purposes only. It is handled under controlled conditions, often within a chemical compounding facility, and stored according to stability requirements such as room temperature or refrigerated environments (e.g., 20 C) depending on study design. No dosage, injection, or administration guidance is provided for human use.
CJC 1295 No DAC appears in research applications related to protein synthesis, fat metabolism, lean mass, recovery, growth, and GH deficiency models. Experimental systems may reference injection methodologies in animal or in vitro contexts strictly for research documentation, including studies reviewed by organizations such as the World Anti Doping Agency. Researchers may also use tools like a peptide calculator to standardize experimental variables and complete required fields for study protocols.
